356 related articles for article (PubMed ID: 38022498)
1. Too much of a good thing: a review of primary immune regulatory disorders.
Tsilifis C; Slatter MA; Gennery AR
Front Immunol; 2023; 14():1279201. PubMed ID: 38022498
[TBL] [Abstract][Full Text] [Related]
2. Defining and targeting patterns of T cell dysfunction in inborn errors of immunity.
Campos JS; Henrickson SE
Front Immunol; 2022; 13():932715. PubMed ID: 36189259
[TBL] [Abstract][Full Text] [Related]
3. Primary Immune Regulatory Disorders and Targeted Therapies.
Kolukısa B; Barış S
Turk J Haematol; 2021 Feb; 38(1):1-14. PubMed ID: 33442967
[TBL] [Abstract][Full Text] [Related]
4. Primary immune regulatory disorders: a growing universe of immune dysregulation.
Chan AY; Torgerson TR
Curr Opin Allergy Clin Immunol; 2020 Dec; 20(6):582-590. PubMed ID: 32941318
[TBL] [Abstract][Full Text] [Related]
5. Infections in Disorders of Immune Regulation.
Thangaraj A; Tyagi R; Suri D; Gupta S
Pathogens; 2024 Mar; 13(3):. PubMed ID: 38535602
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation.
Laberko A; Mukhinа A; Machneva E; Pashchenko O; Bykova T; Vahonina L; Bronin G; Skvortsova Y; Skorobogatova E; Kondratenko I; Fechina L; Shcherbina A; Zubarovskaya L; Balashov D; Rumiantsev A
J Clin Immunol; 2023 Aug; 43(6):1241-1249. PubMed ID: 37009957
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.
Castagnoli R; Delmonte OM; Calzoni E; Notarangelo LD
Front Pediatr; 2019; 7():295. PubMed ID: 31440487
[TBL] [Abstract][Full Text] [Related]
8. Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment.
Lougaris V; Piane FL; Cancrini C; Conti F; Tommasini A; Badolato R; Trizzino A; Zecca M; De Rosa A; Barzaghi F; Pignata C
Ital J Pediatr; 2024 May; 50(1):103. PubMed ID: 38769568
[TBL] [Abstract][Full Text] [Related]
9. Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants.
Aykut A; Durmaz A; Karaca N; Gulez N; Genel F; Celmeli F; Cogurlu MT; Akcan M; Cicek D; Cipe FE; Kiykim A; Yıldıran A; Unluhizarci K; Kilic SS; Aksu G; Ardeniz O; Kutukculer N
Immunol Res; 2024 Apr; ():. PubMed ID: 38644452
[TBL] [Abstract][Full Text] [Related]
10. How I use allogeneic HSCT for adults with inborn errors of immunity.
Burns SO; Morris EC
Blood; 2021 Nov; 138(18):1666-1676. PubMed ID: 34077952
[TBL] [Abstract][Full Text] [Related]
11. Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).
Seidel MG
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):673-679. PubMed ID: 33275670
[TBL] [Abstract][Full Text] [Related]
12. The Use of Biologic Modifiers as a Bridge to Hematopoietic Cell Transplantation in Primary Immune Regulatory Disorders.
Arnold DE; Chellapandian D; Leiding JW
Front Immunol; 2021; 12():692219. PubMed ID: 34248986
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms of immune dysregulation and autoimmunity.
Azizi G; Pouyani MR; Abolhassani H; Sharifi L; Dizaji MZ; Mohammadi J; Mirshafiey A; Aghamohammadi A
Cell Immunol; 2016 Dec; 310():14-26. PubMed ID: 27614846
[TBL] [Abstract][Full Text] [Related]
14. Future of Therapy for Inborn Errors of Immunity.
Perez E
Clin Rev Allergy Immunol; 2022 Aug; 63(1):75-89. PubMed ID: 35020169
[TBL] [Abstract][Full Text] [Related]
15. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency.
Ghosh S; Köstel Bal S; Edwards ESJ; Pillay B; Jiménez Heredia R; Erol Cipe F; Rao G; Salzer E; Zoghi S; Abolhassani H; Momen T; Gostick E; Price DA; Zhang Y; Oler AJ; Gonzaga-Jauregui C; Erman B; Metin A; Ilhan I; Haskologlu S; Islamoglu C; Baskin K; Ceylaner S; Yilmaz E; Unal E; Karakukcu M; Berghuis D; Cole T; Gupta AK; Hauck F; Kogler H; Hoepelman AIM; Baris S; Karakoc-Aydiner E; Ozen A; Kager L; Holzinger D; Paulussen M; Krüger R; Meisel R; Oommen PT; Morris E; Neven B; Worth A; van Montfrans J; Fraaij PLA; Choo S; Dogu F; Davies EG; Burns S; Dückers G; Becker RP; von Bernuth H; Latour S; Faraci M; Gattorno M; Su HC; Pan-Hammarström Q; Hammarström L; Lenardo MJ; Ma CS; Niehues T; Aghamohammadi A; Rezaei N; Ikinciogullari A; Tangye SG; Lankester AC; Boztug K
Blood; 2020 Dec; 136(23):2638-2655. PubMed ID: 32603431
[TBL] [Abstract][Full Text] [Related]
16. Inborn errors of immunity-recent advances in research on the pathogenesis.
Yamashita M; Inoue K; Okano T; Morio T
Inflamm Regen; 2021 Mar; 41(1):9. PubMed ID: 33766139
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
18. Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.
Shimoni A; Nagler A
Cancer Treat Res; 2002; 110():113-36. PubMed ID: 11908195
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficiencies: non-infectious manifestations.
Goudouris ES
J Pediatr (Rio J); 2021; 97 Suppl 1(Suppl 1):S24-S33. PubMed ID: 33176164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
